Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0895 per EA under NDC 62135080530. Its NADAC has been published 120 times since Mar 13, 2024.
Strength
30 mg/1
Manufacturer
Chartwell RX LLCNDC
62135080530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076798On Market Since
10/28/2020
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 120 times since Mar 13, 2024, and over the history we have for it it has declined 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0895 per EA |
|---|---|
| All-time high | $0.1190 (Apr 10, 2024) |
| All-time low | $0.0828 (Nov 20, 2024) |
| 52-week high | $0.1019 |
| 52-week low | $0.0895 |
| Median price | $0.0974 |
| Average price | $0.0993 |
| Largest weekly change | +24.7% (Jun 19, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PIOGLITAZONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Chartwell RX LLC, is $0.0895 per EA (NDC 62135080530), effective Jun 24, 2026.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 17.3%. It has been tracked across 120 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since Mar 13, 2024, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.1190 (Apr 10, 2024), with a median of $0.0974 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PIOGLITAZONE HCL 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 62135080530) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification